(VIANEWS) – MONTEA (MONT.BR), X-FAB (XFAB.PA), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MONTEA (MONT.BR)
25.8% sales growth and 5.79% return on equity
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specialises in logistical property in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space to grow through versatile and innovative property solutions. In this way, Montea creates value for its shareholders. As of 30/09/2023 the property portfolio represented a total surface of 1,921,172 m² spread across 94 locations. Montea NV has been listed on Euronext Brussels (MONT) and Euronext Paris (MONTP) since the end of 2006.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €4.22.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 16.8. Meaning, the purchaser of the share is investing €16.8 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.79%.
Yearly Top and Bottom Value
MONTEA’s stock is valued at €70.90 at 01:20 EST, way under its 52-week high of €80.30 and way higher than its 52-week low of €61.90.
More news about MONTEA.
2. X-FAB (XFAB.PA)
23.3% sales growth and 19.58% return on equity
X-FAB Silicon Foundries SE operates as an analog/mixed-signal semiconductor technology foundry. The company manufactures silicon wafers for automotive, industrial, consumer, medical, and mobile communications, and other applications; and analog/mixed-signal integrated circuits, sensors, and micro-electro-mechanical systems. It also provides manufacturing and design support services for customers that design analog/mixed-signal integrated circuits and other semiconductor devices, as well as engineering and prototyping, outsourcing, technical, and design support services. The company serves integrated device manufacturers, original equipment manufacturers, and fabless semiconductor companies. It operates in Belgium, Germany, the United Kingdom, Austria, France, Switzerland, Denmark, Sweden, Finland, Netherlands, Ireland, Singapore, China, Japan, Thailand, Malaysia, Korea, Taiwan, Hong Kong, New Zealand, the United States, and internationally. The company was founded in 1992 and is based in Tessenderlo, Belgium.
Earnings Per Share
As for profitability, X-FAB has a trailing twelve months EPS of €1.18.
PE Ratio
X-FAB has a trailing twelve months price to earnings ratio of 7.44. Meaning, the purchaser of the share is investing €7.44 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.58%.
More news about X-FAB.
3. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 11.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 32.63. Meaning, the purchaser of the share is investing kr32.63 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.
Moving Average
NAVAMEDIC’s worth is above its 50-day moving average of kr37.27 and higher than its 200-day moving average of kr37.20.
More news about NAVAMEDIC.
4. SATS (SATS.OL)
10.5% sales growth and 3.89% return on equity
Sats ASA provides fitness and training services in Norway, Sweden, Denmark, and Finland. The company offers sportswear, fitness gear, bars, and energy drinks. It operates 275 fitness clubs under the SATS, ELIXIA, Fresh Fitness, SATSonline and SATSYoga brands. The company was founded in 1995 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, SATS has a trailing twelve months EPS of kr0.17.
PE Ratio
SATS has a trailing twelve months price to earnings ratio of 70.59. Meaning, the purchaser of the share is investing kr70.59 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.89%.
More news about SATS.
5. BOUVET (BOUV.OL)
9.7% sales growth and 60.9% return on equity
Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. Bouvet ASA was founded in 1995 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, BOUVET has a trailing twelve months EPS of kr3.09.
PE Ratio
BOUVET has a trailing twelve months price to earnings ratio of 17.86. Meaning, the purchaser of the share is investing kr17.86 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.
Moving Average
BOUVET’s worth is way below its 50-day moving average of kr63.78 and way below its 200-day moving average of kr62.05.
More news about BOUVET.
6. SPBK1 RINGERIKE (RING.OL)
9.7% sales growth and 10.68% return on equity
SpareBank 1 Ringerike Hadeland provides various banking products and services to private and corporate customers in Norway. The company offers saving, current, deposit, and currency accounts; vehicle, house and travel, and animal insurance products, as well as life, child, disability, critical illness, accident, health, and business and personal insurance products; mobile and online banking services; and debit and credit cards. It also provides mortgages; car, boat, and other vehicles; consumer and other loans; and bank guarantees, corporate and construction loans, liquidity loans with a government guarantee, and operating credit for agriculture, as well as factoring, leasing, and overdraft services. In addition, the company offers services for buying and selling property; accounting services; pension products; and savings and investment products. The company was founded in 1833 and is based in Hønefoss, Norway.
Earnings Per Share
As for profitability, SPBK1 RINGERIKE has a trailing twelve months EPS of kr27.14.
PE Ratio
SPBK1 RINGERIKE has a trailing twelve months price to earnings ratio of 11.05. Meaning, the purchaser of the share is investing kr11.05 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.68%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 28, 2023, the estimated forward annual dividend rate is 13.1 and the estimated forward annual dividend yield is 4.4%.
Volume
Today’s last reported volume for SPBK1 RINGERIKE is 40311 which is 3027.31% above its average volume of 1289.
Sales Growth
SPBK1 RINGERIKE’s sales growth is 20.9% for the ongoing quarter and 9.7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 46.7% and 26.8%, respectively.
More news about SPBK1 RINGERIKE.
7. SPAREBANK 1 SR-BK (SRBNK.OL)
6.3% sales growth and 13.14% return on equity
SpareBank 1 SR-Bank ASA, together with its subsidiaries, provides various financial products and services for personal and corporate customers in Southern and Western Norway. The company operates through Retail customers, SME & Agriculture, and Large Corporates segments. It offers its products and services in the areas of savings, loans, insurance, and pensions. The company also provides foreign exchange, administrative securities, commercial properties, leasing, accounting, advisory, estate agency, payroll/HR, securities trading, and investments services; green loans; credit and debit cards; consulting; and banking services. In addition, it facilitates debt and equity funding; and sells real estate properties comprising holiday homes, new builds, and used homes. Further, the company is involved in the customer trading of interest rate instruments; and purchasing of home mortgages. It also serves retail and corporate, small business, and agricultural customers, as well as the public sector. The company was founded in 1839 and is headquartered in Stavanger, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SR-BK has a trailing twelve months EPS of kr14.97.
PE Ratio
SPAREBANK 1 SR-BK has a trailing twelve months price to earnings ratio of 8.01. Meaning, the purchaser of the share is investing kr8.01 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.14%.
Sales Growth
SPAREBANK 1 SR-BK’s sales growth is 28.2% for the current quarter and 6.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 28.2% and a drop 31.7% for the next.
More news about SPAREBANK 1 SR-BK.
